Night Sweats in POTS: Autonomic Dysregulation and Nocturnal Sympathetic Overactivity
Night sweats in POTS patients occur due to autonomic nervous system dysfunction, specifically from abnormal sympathetic nervous system activity during sleep that fails to appropriately decrease at night, combined with thermoregulatory dysregulation that is part of the broader autonomic neuropathy affecting these patients.
Pathophysiologic Mechanisms
The underlying cause relates to the core pathophysiology of POTS itself. Multiple pathophysiologic mechanisms contribute to POTS, including autonomic denervation, hypovolemia, hyperadrenergic stimulation, and these mechanisms often coexist within individual patients 1. Night sweats specifically emerge from two key autonomic disturbances:
Nocturnal Sympathetic Overactivity
Recent evidence demonstrates that POTS patients with nocturnal blood pressure nondipping have elevated nocturnal sympathetic tone and a blunted reduction of skin sympathetic nerve activity (SKNA) between day and night 2. In healthy individuals, sympathetic activity decreases substantially during sleep. However, in POTS patients—particularly those with nocturnal nondipping—this normal circadian reduction fails to occur, maintaining elevated sympathetic output throughout the night that can trigger sweating episodes.
The research shows that the difference in average SKNA between daytime and nighttime is significantly reduced in nondipping POTS patients (0.095 ± 0.099 μV) compared to dipping patients (0.160 ± 0.103 μV) 2. This persistent sympathetic activation during sleep directly drives inappropriate sweating responses.
Autonomic Neuropathy with Sudomotor Dysfunction
Autonomic neuropathy is a recognized pathophysiologic mechanism in POTS 1, 3. Specifically, decreased sweat output on quantitative sudomotor axon reflex testing is the most frequent abnormal finding in POTS patients with autonomic neuropathy, suggesting sympathetic cholinergic neuropathy 4. This sudomotor dysfunction represents abnormal regulation of the sweat glands by the autonomic nervous system, which can manifest as both excessive sweating (hyperhidrosis) and inadequate sweating, often in unpredictable patterns including nocturnal episodes.
Hyperadrenergic Phenotype
Elevated sympathetic tone is one of the three major pathophysiologic mechanisms in POTS 3. Patients with hyperadrenergic POTS have excessive norepinephrine production or impaired reuptake leading to sympathetic overactivity 5. This hyperadrenergic state doesn't simply turn off at night, contributing to nocturnal symptoms including sweating, palpitations, and sleep disturbance.
Clinical Context
The autonomic dysfunction extends beyond simple orthostatic intolerance. A detailed autonomic review of systems should include assessment of thermoregulatory symptoms 1. Night sweats fit within the broader constellation of autonomic symptoms that POTS patients experience, including gastrointestinal dysfunction, bladder symptoms, and temperature regulation abnormalities.
Management Implications
While the guidelines don't specifically address night sweats, understanding the mechanism suggests potential interventions:
Sleeping in head-up tilt position (>10°) is recommended to promote volume expansion and reduce nocturnal diuresis 1. This positioning may also help reduce nocturnal sympathetic activation by improving hemodynamics during sleep.
For patients with prominent hyperadrenergic symptoms, central sympatholytic agents such as clonidine (0.1-0.2 mg up to 3 times per day) or methyldopa may be considered 1. Taking these medications at bedtime could potentially reduce nocturnal sympathetic overactivity and associated night sweats.
Low-dose propranolol (10-20 mg 4 times per day) is recommended for POTS 1. A bedtime dose may help dampen nocturnal sympathetic activity, though this hasn't been specifically studied for night sweats.
Important Caveats
The thermoregulatory sweat test and quantitative sudomotor axonal reflex test are mentioned as autonomic testing options 1, but pathophysiological subtyping is not recommended during initial screening and diagnosis due to lack of standardized tools 1. Night sweats should be recognized as part of the autonomic dysfunction spectrum rather than requiring specific diagnostic testing beyond the standard POTS evaluation.
Patients should avoid warm environments as a general principle 1, which extends to maintaining appropriate bedroom temperature and using breathable bedding to minimize triggers for nocturnal sweating episodes.